Iterum Therapeutics plc (ITRMF) Other Operating Expenses (2018 - 2025)

Iterum Therapeutics has reported Other Operating Expenses for 3 years, with the latest figure at $369000.0 in Q3 2025.

• On a quarterly basis, Other Operating Expenses changed N/A year-over-year to $369000.0 in Q3 2025; TTM through Sep 2025 was $1.3 million, a N/A change from a year earlier, with the FY2024 full-year figure at $254000.0, changed N/A from the prior year.
• Other Operating Expenses was $369000.0 for Q3 2025 at Iterum Therapeutics, up from $345000.0 in the prior quarter.
• The five-year high for Other Operating Expenses was $369000.0 in Q3 2025, with the low at $254000.0 in Q4 2024.